Olema Pharmaceuticals Inc.
OLMA
|
|
|
|
Trading Volume | 18,136 |
|
17.14 - 9.61 |
Market Cap Full | $ 632.6M |
Quarterly +
2025 | 2024 | 2023 | 2022 | |
---|---|---|---|---|
Q1 | 1.1% | -19.4% | 41.6% | -56.1% |
Q2 | - | 2.9% | 160.2% | -2.4% |
Q3 | - | -28.7% | 36.8% | -32.2% |
Q4 | - | -38.2% | 20.3% | -11.2% |
Monthly +
J | F | M | A | M | J | J | A | S | O | N | D |
2025 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
1.1 | - | - | - | - | - | - | - | - | - | - | - |
2024 | |||||||||||
-7.1 | -4.9 | -8.8 | -12.8 | -1.7 | 15.6 | 44.6 | -28.7 | - | - | - | - |
2023 | |||||||||||
97.1 | -15.1 | -15.4 | 38 | 7.9 | 74.7 | -4.2 | 17.3 | 21.7 | 7.6 | 5 | 0.6 |
2022 | |||||||||||
-32.3 | -27.2 | -10.9 | -36.8 | 8.5 | 42.3 | 23.1 | -21.2 | -30.1 | 36.2 | -23.7 | -14.6 |
2021 | |||||||||||
-15.5 | -1.8 | -26.5 | -4 | -4.9 | -0 | -17 | 28.8 | -7.9 | -2 | -67.6 | 8.5 |
2020 | |||||||||||
- | - | - | - | - | - | - | - | - | - | - | -1.5 |
EPS
2023 | 2022 | 2021 | 2020 | |
---|---|---|---|---|
Q1 | -0.7 | -0.6 | -0.4 | 0 |
Q2 | -0.5 | -0.8 | -0.4 | 0 |
Q3 | -0.5 | -0.6 | -0.5 | 0 |
Q4 | 0 | -0.7 | -0.5 | 0 |
A | -1.67 | -2.6 | -1.8 | -3.4 |